Annual Lung SPORE Workshop (Abstract Submission)

76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Sun, 03/10/2024 - 20:25 Alice Berger ahberger@fredhutch.org 2066676281 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic discovery of osimertinib resistance variants using CRISPR prime editing Alice Berger Fred Hutch Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 09:20 Andrey Ivanov andrey.ivanov@emory.edu (404) 727-6343 Session 6: Cancer Biology The AVERON Notebook: a computational approach to druggable cancer dependencies enabled by mutant-directed protein-protein interactions. Hongyue (Nicole) Chen Emory University
  • First Name: Brian
    Last Name: Revennaugh
    Affiliation: Emory University
  • First Name: Haian
    Last Name: Fu
    Affiliation: Emory University
  • First Name: Andrey
    Last Name: Ivanov
    Affiliation: Emory University
Abstract_Submission.pdf No Approved to be a Speaker
Thu, 03/14/2024 - 01:26 Alexandra Potter apotter8@mgh.harvard.edu 2538829777 Session 2: Health Disparities in Lung Cancer The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility Alexandra Potter Massachusetts General Hospital
  • First Name: Priyanka
    Last Name: Senthil
    Affiliation: Massachusetts General Hospital
  • First Name: Quiana
    Last Name: Guo
    Affiliation: Massachusetts General Hospital
  • First Name: Arian
    Last Name: Mansur
    Affiliation: Massachusetts General Hospital
  • First Name: Uma
    Last Name: Sachdeva
    Affiliation: Massachusetts General Hospital
  • First Name: Hugh
    Last Name: Auchincloss
    Affiliation: Massachusetts General Hospital
  • First Name: Chi-Fu Jeffrey
    Last Name: Yang
    Affiliation: Massachusetts General Hospital
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:09 Arnaud Augert arnaud.augert@yale.edu Session 4: Small Cell Lung Cancer The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC Arnaud Augert Yale University Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Thu, 02/29/2024 - 15:57 Bluma Lesch bluma.lesch@yale.edu 203-737-1074 Session 6: Cancer Biology Mechanisms of epigenetic sensitization to lung cancer risk Benjamin Walters Yale University
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 19:37 Boning Gao boning.gao@utsouthwestern.edu 2146484915 Session 6: Cancer Biology New human cell line models for the study of pathogenesis of SARS-CoV-2 infection Boning Gao UT Southwestern
  • First Name: Ian
    Last Name: Boys
    Affiliation: UT Southwestern
  • First Name: Sara
    Last Name: El Zahed
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: Long Shan
    Last Name: Li
    Affiliation: UT Southwestern
  • First Name: Luc
    Last Name: Girard
    Affiliation: UT Southwestern
  • First Name: Hyunsil
    Last Name: Park
    Affiliation: UT Southwestern
  • First Name: Victor
    Last Name: Stastny
    Affiliation: UT Southwestern
  • First Name: Kenneth
    Last Name: Huffman
    Affiliation: UT Southwestern
  • First Name: Shreoshi Pal
    Last Name: Choudhuri
    Affiliation: UT Southwestern
  • First Name: Kimberly
    Last Name: Batten
    Affiliation: UT Southwestern
  • First Name: Matthew
    Last Name: Esparza
    Affiliation: UT Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: UT Southwestern
  • First Name: Lisa
    Last Name: Miorin
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Jerry
    Last Name: Shay
    Affiliation: UT Southwestern
  • First Name: Wendy
    Last Name: Maury
    Affiliation: University of Iowa
  • First Name: Beatriz
    Last Name: Fontoura
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Schoggins
    Affiliation: UT Southwestern
  • First Name: Adolfo
    Last Name: Garcia-Sastre
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:03 Caro Kravitz caro.kravitz@yale.edu Session 6: Cancer Biology The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis Caro Kravitz Yale University
  • First Name: Kiran
    Last Name: Patel
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Yale
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale
  • First Name: Emily
    Last Name: Wingrove
    Affiliation: Yale
  • First Name: Laura
    Last Name: Stevens
    Affiliation: Yale
  • First Name: Thomas
    Last Name: Westbrook
    Affiliation: Baylor
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 03:47 Catherine Meador cbmeador@mgh.harvard.edu 9192603477 Session 4: Small Cell Lung Cancer Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling Catherine Meador Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Talal
    Last Name: El Zarif
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Xintao
    Last Name: Qiu
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Ji-Heui
    Last Name: Seo
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Davidsohn
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Hunter
    Last Name: Savignano
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Gitanjali
    Last Name: Lakshminaranan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Heather
    Last Name: McClure
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: John
    Last Name: Canniff
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Brad
    Last Name: Fortunato
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Rong
    Last Name: Li
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Mandeep
    Last Name: Banwait
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Karl
    Last Name: Semaan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Marc
    Last Name: Eid
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Henry
    Last Name: Long
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Yin
    Last Name: Hung
    Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Navin
    Last Name: Mahadevan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: David
    Last Name: Barbie
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Oser
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Zofia
    Last Name: Piotrowska
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Toni
    Last Name: Choueiri
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Sylvan
    Last Name: Baca
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Aaron
    Last Name: Hata
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Matthew
    Last Name: Freedman
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Jacob
    Last Name: Berchuck
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Wed, 04/03/2024 - 17:40 Cecil Han ch1182@georgetown.edu 2026878634 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies, Session 6: Cancer Biology The emerging role of deubiquitinating enzyme USP13 in lung cancer plasticity Juntae Kwon Georgetown University School of Medicine Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Wed, 03/06/2024 - 18:26 David MacPherson dmacpher@fredhutch.org 2066676464 Session 4: Small Cell Lung Cancer In vivo functional screens identify drivers of chemoresistance in small cell lung cancer Scott Best Fred Hutch
  • First Name: Lauren
    Last Name: Brumage
    Affiliation: Fred Hutch
  • First Name: Daniel
    Last Name: Hippe
    Affiliation: Fred Hutch
  • First Name: Eli
    Last Name: Grunblatt
    Affiliation: Fred Hutch
  • First Name: Pritha
    Last Name: Chanana
    Affiliation: Fred Hutch
  • First Name: Feinan
    Last Name: Wu
    Affiliation: Fred Hutch
  • First Name: Richard
    Last Name: Ivey
    Affiliation: Fred Hutch
  • First Name: Jacob
    Last Name: Kennedy
    Affiliation: Fred Hutch
  • First Name: Myung Chang
    Last Name: Lee
    Affiliation: Genentech
  • First Name: Zhe
    Last Name: Ying
    Affiliation: Fred Hutch
  • First Name: Ali
    Last Name: Ibrahim
    Affiliation: Fred Hutch
  • First Name: Jae Heun
    Last Name: Chung
    Affiliation: Fred Hutch
  • First Name: Anna
    Last Name: Vigil
    Affiliation: Fred Hutch
  • First Name: Jackson
    Last Name: Fatherree
    Affiliation: Fred Hutch
  • First Name: Slobodan
    Last Name: Beronja
    Affiliation: Fred Hutch
  • First Name: Patrick
    Last Name: Paddison
    Affiliation: Fred Hutch
  • First Name: Lucas
    Last Name: Sullivan
    Affiliation: Fred Hutch
  • First Name: Amanda
    Last Name: Paulovich
    Affiliation: Fred Hutch
  • First Name: Barzin
    Last Name: Nabet
    Affiliation: Genentech
  • First Name: David
    Last Name: MacPherson
    Affiliation: Fred Hutch
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:46 Don Nguyen don.nguyen@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis Don Nguyen Yale School of Medicine Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:15 Elisabeth Martinez elisabeth.martinez@utsouthwestern.edu Session 4: Small Cell Lung Cancer Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer Aiden Nguyen UTSW
  • First Name: Clarissa
    Last Name: Nunez
    Affiliation: UTSW
  • First Name: Tram Anh
    Last Name: Tran
    Affiliation: UTSW
  • First Name: John
    Last Name: Minna
    Affiliation: UTSW
  • First Name: Elisabeth
    Last Name: Martinez
    Affiliation: UTSW
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:55 Elda Railey erailey@researchadvocacy.org 2146839937 Session 6: Cancer Biology Identifying Unique Challenges and Opportunities in Incorporating Patient Advocates into the Lung Cancer SPORE Program Elda Railey UTSWMC/MDACC Lung SPORe and Research Advocacy Network
  • First Name: John
    Last Name: Minna
    Affiliation: UTSWMC
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:12 Esra Akbay esra.akbay@utsouthwestern.edu 2146484159 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models Esra Akbay UT Southwestern Medical Center Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:56 Florian Fintelmann fintelmann@mgh.harvard.edu 6178490063 Session 5: Early Detection and Screening Significance of image acquisition parameters for Sybil’s ability to predict future lung cancer risk on low-dose chest computed tomography Judit Simon MGH
  • First Name: Peter
    Last Name: Mikhael
    Affiliation: MIT
  • First Name: Alexander
    Last Name: Graur
    Affiliation: MGH
  • First Name: Regina
    Last Name: Barzilay
    Affiliation: MIT
  • First Name: Lecia
    Last Name: Sequist
    Affiliation: MGH
  • First Name: Florian
    Last Name: Fintelmann
    Affiliation: MGH
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 09:40 Francisco Exposito francisco.exposito@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer Francisco Exposito Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Abstract_Submission.pdf No Approved to be a Poster Presenter